Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q478
SBA

SBA — Single Best Answer · Review

Question 478

Pharmacology → General

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID 13d9f9f5-a709-4cdf-aaaa-066fb650032a

Classification

Speciality
Obstetrics and Gynaecology
Group
Basic
Title
Pharmacology
Topic
General
Subtopic 1
Adrenergic Agents
Subtopic 2
Clonidine
Subtopic 3
Perioperative and adverse effects
Question Type
SBA

Question

SSBA
Question Header
A patient receiving clonidine is assessed before surgery. Which combination of effects is characteristic of this drug?
Question Stem
Select the single best answer.

Options

A Increased catecholamine release with increased anaesthetic requirement
B Suppressed catecholamine release with reduced minimum alveolar concentration of volatile anaesthetic agents
C Dopamine receptor blockade with increased minimum alveolar concentration
D Beta-2 blockade with bronchodilatation and reduced sedation
E Increased catecholamine release with marked diuresis

Explanation

Clonidine is an alpha-adrenergic agonist that acts centrally at presynaptic alpha-2 receptors, suppressing catecholamine release by negative feedback. It has analgesic and sedative properties, and preoperative administration reduces the minimum alveolar concentration of volatile anaesthetic agents.

Option Validity

A) Clonidine suppresses rather than increases catecholamine release and reduces anaesthetic requirement.

C) Dopamine receptor blockade characterises antipsychotic drugs rather than clonidine.

D) Clonidine acts through central alpha-2 receptors, not beta-2 blockade.

E) Increased catecholamine release and marked diuresis are not characteristic effects of clonidine.

Further Reading

Saxena R. Textbook for MRCOG-1. Chapter 12: Pharmacology. Adrenergic Agents, p.345.

Source & metrics

Authored Difficulty
5.00
Evaluation Score
—
Destination
Site
Source
Saxena - MRCOG-1 Basic Sciences - Pharmacology - General
Source Section
Adrenergic Agents
Source Locator
Chapter 12, p.345
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question